Papa Medical, which sells branded cannabis vape devices primarily in North American and Europe, announced terms for its IPO on Friday.
The City of Industry, CA-based company plans to raise $5 million by offering 1.3 million shares at $4. At the proposed price, Papa Medical would command a market value of $85 million.
Papa Medical sells cannabis e-vapor products under the Cannapresso brand. As of September 30, 2024, the company has launched approximately 50 series of e-vapors. It sells its products in North America and Europe, as well as the UAE and elsewhere.
Papa Medical was founded in 2018 and booked $47 million in sales for the 12 months ended March 31, 2025. It plans to list on the Nasdaq under the symbol PAPA. Tiger Brokers and TFI Securities are the joint bookrunners on the deal.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。